A Phase 1, Open-Label, Non-Randomized Study of OPB-31121 in Patients With Advanced Solid Tumors.
Latest Information Update: 08 Nov 2021
At a glance
- Drugs OPB 31121 (Primary)
- Indications Solid tumours
- Focus Adverse reactions
- Sponsors Korea Otsuka Pharmaceutical
- 25 Mar 2011 New trial record